This site is intended for Healthcare professionals only.

Suven Life gets patents from Europe, South Korea


Suven Life gets patents from Europe, South Korea

New Delhi: Suven Life Sciences said it has been granted a product patent by Europe and South Korea each for a new chemical entity (NCE) used in the treatment of disorders associated with neurodegenerative diseases.

These patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.

“We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally,” Suven Life CEO Venkat Jasti said.

The granted claims of patents are being developed as therapeutic agents useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), Huntington’s disease, Parkinson’s and schizophrenia, it added



Source: PTI
0 comment(s) on Suven Life gets patents from Europe, South Korea

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted